Atezolizumab for first-line treatment of metastatic nonsquamous non-small cell lung cancer: what makes the difference?

J Thorac Dis. 2018 Sep;10(Suppl 26):S3241-S3243. doi: 10.21037/jtd.2018.08.82.
No abstract available

Publication types

  • Editorial
  • Comment